SUSTAINED-RELEASE MICROPARTICLE-BASED ANTIREJECTION THERAPY THROUGH ENHANCEMENT OF REGULATORY T CELLS (SMARTER) PLATFORM FOR VCA IMMUNOMODULATION
$645,000FY2021Defense Health AgencyDOD
University Of Pittsburgh - Of The Commonwealth System Of Higher Education